Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation

Table 1 Characteristics of children with de novo hepatitis B infection after liver transplantation

	Pre-operation data (serum)			Allograft			De novo HBV infection				HBV status follow-up
No.	HBsAb (IU/mL)	HBcAb (IU/mL)	HBVDNA (IU/mL)	HBsAb (IU/mL)	HBcAb (IU/mL)	HBVDNA/cccDNA (copies/cell)	Time after LT (mo)	HBsAg (IU/mL)	Serum HBVDNA (IU/mL)	Liver enzymes	HBsAb (IU/mL)	Serum HBVDNA (IU/mL)	Liver enzymes	Follow-up (mo)
1	< 2	1.04	< 100	251.8	0.010	2.57/0.08	25.4	1348	1.62 × E8	N	4745	1.62 × E8	N	35.3
2	< 2	1.36	< 100	462.4	0.007	Neg/neg	10.6	164.9	1.12 × E2	AN	5791	1.62 × E8	N	17.0
3	< 2	0.98	< 100	262.5	0.339	1.50/0.09	12	3608	2.90 × E9	N	3608	2.9 × E9	N	16.8
4	164.4	0.03	< 100	< 2	0.007	12.4/0.15	3.4	746.1	7.14 × E8	AN	1866	7.14 × E8	AN	4.0
5	31.4	0.23	< 100	210.0	0.009	3.61/0.09	8.7	2345	1.46 × E8	N	3213	1.46 × E8	N	15.2

HBsAb: Hepatitis B surface antibody; HBcAb: Hepatitis B core antibody; HBV: Hepatitis B virus; cccDNA: Covalently closed circular DNA; LT: Liver transplantation; N: Normal; AN: Abnormal.